Lv5
810 积分 2023-04-14 加入
A basic insight into aptamer-drug conjugates (ApDCs)
8天前
已完结
Advances in aptamer-mediated targeted delivery system for cancer treatment
8天前
已完结
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer
20天前
已完结
抗体类药物非临床研究相关种属选择的一般考虑
1个月前
已完结
Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy
1个月前
已完结
Non-clinical Safety Evaluation of Biotherapeutics - Challenges, Opportunities and new Insights
1个月前
已完结
Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturing
1个月前
已完结
An Introduction to the Regulatory and Nonclinical Aspects of the Nonclinical Development of Antibody Drug Conjugates
1个月前
已完结
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology
1个月前
已完结
Preclinical formulations for discovery and toxicology: physicochemical challenges
3个月前
已完结
皖公网安备34019202002308
